Approval Is Not Exposure: The COVID-19 Category Error

Regulatory approval and accumulated human exposure are distinct evidentiary categories. This medical-policy case study identifies a COVID-19 category error: treating indication-specific regulatory status as a proxy for the total evidence available about a product. Using Anthony Fauci's March 2020 diary, the paper examines how hydroxychloroquine and remdesivir were compared, then applies the same distinction to mRNA vaccine authorization and postauthorization myocarditis evidence. It does not claim that hydroxychloroquine treated COVID-19, determine vaccine effectiveness or net benefit, or provide clinical advice. The analysis is a product of Nested Causal Modelling but presents its findings in ordinary regulatory and evidentiary language.Two "explainer" videos are included that were generated by Gemini Notebook (Formerly NotebookLM). A The markdown file: A_Volunteer_to_Exemplify_the_Problem.md is the text of a column article posted to my websitte: http://sidhubbard.com describing the timely release of a diary that served as a volunteer to exemplify the category error. The examples in my draft of this paper were a bit confusing. Reading the day by day diary watching the exact category error I was identifying made the paper finish itself.